SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: scaram(o)uche who wrote ()2/27/2000 3:13:00 PM
From: dalroi  Read Replies (1) of 2243
 
Found it :-)

ok lets boldly go where most of you dont want to venture
Europe
(yep rick this will be my one and only tout for the "old world")

seems to me that lots off stocks at home still dont carry the "relative" correct valuation
WARNING whats correct those days
so some examples some stocks even have adrs here others are mostly on london
quotes available per yahoo finance
uk&ireland
for starters
1/ Celltech
after merger with medeva has a nice broad pipeline with lots off AB stuff in it
RUMOr seems they stopped developping ab against ovarian cancer
BUT price off antisoma in london and on easdaq up 60%
mk +- 250m$ now (compared to IMCL peanuts)
i sus^pect munch ?
2/ oxford glycoscience
YES the PETER PRINCIPLE starts to work here too
they did a SPO friday and price up 28%
nice proteomics co silly cheap on MK
have nice agrement with incy
www.ogs.com
3/ Cambridge antibody technologie
abgx for 1/3 of the price
4/ genxy

gentlemen and ladies do your own d&d but i think prices will move up sharply
cat and celltech +10% friday

Cheers
Stefaan

ps cant resist to mention
QTRN and ELN like the memorable Cato
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext